Axys Pharmaceuticals, Inc. announced that Axys Advanced Technologies, Inc. (AAT), its combinatorial chemistry subsidiary, entered into an agreement with Bristol-Myers Squibb Company (BMS) to provide them with diverse compounds for pharmaceutical screening. Axys will also provide BMS with enabling technologies for reproducing and expanding the library chemistries. This agreement provides for payments to AAT for Read more about Axys Announces Screening Agreement With Bristol-Myers Squibb[…]